Effects of Head and Neck Cooling and Heating on Fatigue in Multiple Sclerosis and Healthy Men

NCT ID: NCT06370403

Last Updated: 2024-04-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-02-04

Study Completion Date

2017-01-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Local head and neck cooling strategies can help reduce multiple sclerosis-related fatigue, while heating can exacerbate heat-related fatigue. However, no study has detailed the peripheral and central responses to head and neck cooling (at 18°C) and heating (at 43 ± 1°C next to the scalp and neck skin) during fatiguing isometric exercise in non-challenging ambient temperature in multiple sclerosis and healthy male subjects. In addition, there is a lack of data describing the effects of head and neck cooling/heating and strenuous exercise on blood markers, muscle temperature, motor accuracy, and rate of perceived exertion. The investigators hypothesized that: (i) men with multiple sclerosis would be more affected by central and peripheral fatigue compared to healthy subjects; (ii) local cooling will result in greater central fatigue but will be associated with greater peripheral fatigue, whereas heating will result in greater central and peripheral fatigue in multiple sclerosis men; (iv) local cooling and heating will have a greater effect on the release of stress hormones, rate of perceived exertion and motor accuracy compared to the control condition in both multiple sclerosis and healthy groups.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

The researchers who analyzed the venous blood samples were blinded.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cooling of the head and neck in multiple sclerosis and healthy subjects

Multiple sclerosis and healthy male subjects participated in the head and neck cooling program. During cooling procedure, the participant performed fatiguing isometric motor task with a head and neck cooling helmet at (18°C next to the head and neck skin).

Group Type EXPERIMENTAL

Cooling of the head and neck

Intervention Type OTHER

Cooling of the head and neck at 18°C next to the head and neck skin in multiple sclerosis and healthy subjects

Heating of the head and neck in multiple sclerosis and healthy subjects

Multiple sclerosis and healthy male subjects participated in the head and heating program. During heating procedure, the participant performed fatiguing isometric motor task with a head and neck heating helmet at (43°C± 1°C next to the head and neck skin).

Group Type EXPERIMENTAL

Heating of the head and neck

Intervention Type OTHER

Heating of the head and neck at 43 ± 1°C next to the head and neck skin in multiple sclerosis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cooling of the head and neck

Cooling of the head and neck at 18°C next to the head and neck skin in multiple sclerosis and healthy subjects

Intervention Type OTHER

Heating of the head and neck

Heating of the head and neck at 43 ± 1°C next to the head and neck skin in multiple sclerosis

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Relapsing-remitting multiple sclerosis disease course according to McDonald criteria
* Expanded Disability Status Scale less than 4 points and Fatigue Severity Scale score greater than 5 points in participants with multiple sclerosis
* Males
* Age between 18 and 45 years
* Sufficient tolerance to electrical stimulation

Exclusion Criteria

* Physical limitations that would impair the ability to perform neuromuscular testing
* Mental disorders, such as depression or anxiety, due to their recognized association with fatigue
* Involvement in temperature manipulation program for ≥ 3 months
* Attending any excessive physical exercise or sports programs
* With blood/needle phobia
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lithuanian Sports University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gintarė Daukšaitė

Role: PRINCIPAL_INVESTIGATOR

Lithuanian Sports University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lithuanian Sports University

Kaunas, , Lithuania

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Lithuania

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LithuanianSportsU-21

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.